Long Term Follow up of EVEROLD study
Study Type
OBSERVATIONAL
Enrollment
260
Chu Amiens
Amiens, France
RECRUITINGCHU Bordeaux
Bordeaux, France
RECRUITINGPatient survival
Patient survival at last follow-up
Time frame: up to 12 years
Graft survival
Graft survival at last follow-up
Time frame: up to 12 years
Rejection rate
Biopsy proven rejection
Time frame: up to 12 years
Infection rate
All infections requiring hospitalization
Time frame: up to 12 years
Major cardiovascular events
Time frame: up to 12 years
Cancer rate
Skin cancer, solid organ tumor and hematological cancer
Time frame: up to 12 years
Hospitalization
Number of hospitalization, hospital stay, reason for hospitalization
Time frame: up to 12 years
eGFR
estimated GFR (MDRD and CKD-EPI)
Time frame: up to 12 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Chu Brest
Brest, France
CHU Lille
Lille, France
RECRUITINGCHU Limoges
Limoges, France
RECRUITINGCHU Nice Pasteur 2
Nice, France
RECRUITINGCHU Nice
Nice, France
RECRUITINGHôpital Necker
Paris, France
RECRUITINGChu Poitiers
Poitiers, France
RECRUITINGCHU Rennes
Rennes, France
RECRUITING...and 4 more locations